PMC:7073332 / 18032-18233 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"539","span":{"begin":145,"end":153},"obj":"Species"},{"id":"552","span":{"begin":158,"end":175},"obj":"Disease"}],"attributes":[{"id":"A539","pred":"tao:has_database_id","subj":"539","obj":"Tax:1335626"},{"id":"A552","pred":"tao:has_database_id","subj":"552","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"To further validate the 135 repurposable drugs against HCoVs, we first performed gene set enrichment analysis (GSEA) using transcriptome data of MERS-CoV and SARS-CoV infected host cells (see Methods)."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T87","span":{"begin":81,"end":85},"obj":"Body_part"},{"id":"T88","span":{"begin":181,"end":186},"obj":"Body_part"}],"attributes":[{"id":"A87","pred":"fma_id","subj":"T87","obj":"http://purl.org/sig/ont/fma/fma74402"},{"id":"A88","pred":"fma_id","subj":"T88","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"To further validate the 135 repurposable drugs against HCoVs, we first performed gene set enrichment analysis (GSEA) using transcriptome data of MERS-CoV and SARS-CoV infected host cells (see Methods)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T69","span":{"begin":158,"end":166},"obj":"Disease"}],"attributes":[{"id":"A69","pred":"mondo_id","subj":"T69","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"To further validate the 135 repurposable drugs against HCoVs, we first performed gene set enrichment analysis (GSEA) using transcriptome data of MERS-CoV and SARS-CoV infected host cells (see Methods)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T119","span":{"begin":81,"end":85},"obj":"http://purl.obolibrary.org/obo/OGG_0000000002"},{"id":"T120","span":{"begin":181,"end":186},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"To further validate the 135 repurposable drugs against HCoVs, we first performed gene set enrichment analysis (GSEA) using transcriptome data of MERS-CoV and SARS-CoV infected host cells (see Methods)."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T172","span":{"begin":41,"end":46},"obj":"Chemical"}],"attributes":[{"id":"A172","pred":"chebi_id","subj":"T172","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"}],"text":"To further validate the 135 repurposable drugs against HCoVs, we first performed gene set enrichment analysis (GSEA) using transcriptome data of MERS-CoV and SARS-CoV infected host cells (see Methods)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T110","span":{"begin":0,"end":201},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"To further validate the 135 repurposable drugs against HCoVs, we first performed gene set enrichment analysis (GSEA) using transcriptome data of MERS-CoV and SARS-CoV infected host cells (see Methods)."}